Public Company News
New Oriental Announces Results for the Second Fiscal Quarter Ended November 30, 2025
BEIJING, Jan. 28, 2026 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced its unaudited financial results for the second fiscal quarter ended November 30, 2025...
2026-01-28 18:02
7488
NetEase Cloud Music Inc. to Report Fiscal Year 2025 Financial Results on February 11, 2026
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider in China, today announced that it will report its financial results for the fiscal year of 2025 ended December 31, 2025 on Wednesday, Febru...
2026-01-28 17:18
3605
SK hynix to establish U.S. arm specialized in AI solutions
- 'AI Company,' aims to become a key partner in the AI data center ecosystem - As the hub for SK Group's AI strategies, AI Co. will help accelerate AI advancement in global markets, including US and S. Korea. - "SK hynix will proactively seize opportunities in the upcoming AI era and deliver ex...
2026-01-28 17:18
6870
Yutong Bus Reports Continued Sales Growth in 2025, Advancing Sustainable Public Transportation Worldwide
Steady operating performance, innovation-driven growth, and ESG integration reinforce long-term value creation ZHENGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a global commercial vehicle manufacturer, delivered steady and sustainable operating performance in 2...
2026-01-28 16:55
7496
SK hynix Announces FY25 Financial Results… Posts Record-High Results and Delivers Highest Shareholder Returns
* Achieves all-time high annual and quarterly results, driven by AI memory competitiveness and high value-added products including HBM * Reports FY2025 revenue of 97.1467 trillion won, operating profit of 47.2063 trillion won, net profit of 42.9479 trillion won * Reports 4Q25 revenue of 32.8...
2026-01-28 16:42
8849
Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE:DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its fourth quarter and fiscal ...
2026-01-28 16:30
3585
NetEase to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the fourth quarter and fiscal year 2025 onWednesday, February 11, 2026, ...
2026-01-28 16:30
4203
GUI Model Second Only to Claude: MiningLamp Technology's AI-powered Global Marketing Platform Wins CICAS Grand Prize
SUZHOU, China, Jan. 28, 2026 /PRNewswire/ -- On January 25th, the finals of the 3rd China's Innovation Challenge on Artificial Intelligence Application Scene (CICAS) concluded in Suzhou, Jiangsu Province. As one of China's most influential AI competitions, this year's event was jointly organized ...
2026-01-28 16:14
5271
Yili Group Kicks Off 2026 with Strategic Partner Conferences in Southeast Asia
BANGKOK and BANDUNG, Indonesia, Jan. 28, 2026 /PRNewswire/ -- As the new year begins, Yili Group continues to build momentum in Southeast Asia. Recently, Yili's subsidiaries in Thailand and Indonesia successfully held their 2026 Top Partners Conferences in Bangkok and Bandung, respectively. The ...
2026-01-28 14:32
5234
Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More
Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obes...
2026-01-28 12:08
4479
Agoda Unveils Goa and Dubai as Top Choices for Republic Day Long Weekend Escapes
Domestic accommodation searches for January 23 - 26 more than doubled (115%) year-on-year, while outbound travel increased by 63% SINGAPORE, Jan. 28, 2026 /PRNewswire/ -- With the Republic Day holiday falling alongside a weekend in 2026, Indian travellers were already planning their next break a...
2026-01-28 10:30
5691
Pony.ai Expands Robotaxi Commercialization With ATBB, Advancing Asset-Light Scaling Across Urban and Airport Mobility
BEIJING, Jan. 28, 2026 /PRNewswire/ -- Pony.ai, a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced a strategic partnership with Beijing ATBB Travel & Express Service Co., Ltd., a premium mobility service provider in Chi...
2026-01-28 10:00
4538
Webull launches Advanced US Options for Australian investors
* Australian investors to gain access to sophisticated multi-leg option strategies * New Option Builder tool guides users to construct strategies and understand outcomes * AI-powered daily summaries deliver volatility insights and risk analysis * Priced at US$0.50 per contract, the offerin...
2026-01-28 06:00
8182
European Investment Bank (EIB) backs Minesto in developing an investment case for the EU's first Tidal Energy Dragon Farm
GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- Minesto, leading ocean energy developer, has on a complementary basis been selected for in-depth investment advisory support by the European Investment Bank (EIB) under the PDA (Project Development Assistance) programme. The program offers extensi...
2026-01-27 22:53
6948
Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center...
2026-01-27 22:00
7661
NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Bi...
2026-01-27 21:55
10608
Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem
HONG KONG, Jan. 27, 2026 /PRNewswire/ -- Home Control International Limited (" Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1747.HK) is pleased to announce that it has entered into a Strategic Memorandum of Understanding (MoU) with Nanyang Technological ...
2026-01-27 21:25
6931
AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities
The AU$150,000 partnership will create a dedicated agriculture program for the university. DULUTH, Ga., Jan. 28, 2026 /PRNewswire/ -- AGCO Foundation, a private foundation working to transform lives in farming communities, announced a new partnership with the University of Sydney Business School...
2026-01-27 21:15
5674
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....
2026-01-27 21:00
8374
Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease
* Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. * License and collaboration agreement strengthen Boehringer's inflammatory disease pipeline with a potential, first-in-class, pre-clinical asset. *...
2026-01-27 18:40
5937
Week's Top Stories
Most Reposted
Visa partners with Laufey to spread the magic of travel in Asia Pacific; to be Official Payment Partner for Laufey: A Matter of Time Tour
[Picked up by 310 media titles]
2026-03-04 12:35
TelkomMetra Streamlines Business Portfolio, AdMedika Group Poised to Enter a New Growth Phase on Regional Level Under Fullerton Health
[Picked up by 295 media titles]
2026-03-09 21:36
Klook's Spring Readiness Index shows how Asia's travelers are preparing for spring travel across Japan, South Korea, and Mainland China
[Picked up by 292 media titles]
2026-03-03 15:49
COL and NASDAQ-Listed BeLive Holdings Unveil World's First "Microdrama in a Box" in Headline Hong Kong FILMART 2026 Launch
[Picked up by 287 media titles]
2026-03-05 17:14
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
[Picked up by 267 media titles]
2026-03-04 10:00
